These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serotonin and pulmonary hypertension--from bench to bedside? MacLean MR; Dempsie Y Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424 [TBL] [Abstract][Full Text] [Related]
5. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho. MacLean MR; Fanburg B; Hill N; Lazarus HM; Pack TF; Palacios M; Penumatsa KC; Wring SA Compr Physiol; 2022 Aug; 12(4):4103-4118. PubMed ID: 36036567 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension and the serotonin hypothesis: where are we now? MacLean MR Int J Clin Pract Suppl; 2007 Sep; (156):27-31. PubMed ID: 17663674 [TBL] [Abstract][Full Text] [Related]
9. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701 [TBL] [Abstract][Full Text] [Related]
10. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts. Mair KM; MacLean MR; Morecroft I; Dempsie Y; Palmer TM Br J Pharmacol; 2008 Oct; 155(4):606-16. PubMed ID: 18695640 [TBL] [Abstract][Full Text] [Related]
11. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension. Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266 [TBL] [Abstract][Full Text] [Related]
12. [Serotonin hypothesis and pulmonary artery hypertension]. Kloza M; Baranowska-Kuczko M; Pędzińska-Betiuk A; Jackowski K; Kozłowska H Postepy Hig Med Dosw (Online); 2014 Jun; 68():738-48. PubMed ID: 24934532 [TBL] [Abstract][Full Text] [Related]
13. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension. Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806 [TBL] [Abstract][Full Text] [Related]
14. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988 [TBL] [Abstract][Full Text] [Related]
16. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Launay JM; Hervé P; Peoc'h K; Tournois C; Callebert J; Nebigil CG; Etienne N; Drouet L; Humbert M; Simonneau G; Maroteaux L Nat Med; 2002 Oct; 8(10):1129-35. PubMed ID: 12244304 [TBL] [Abstract][Full Text] [Related]
17. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463 [TBL] [Abstract][Full Text] [Related]
18. Too late, again? Jones NL Can Respir J; 2001; 8(3):127-8. PubMed ID: 11420587 [No Abstract] [Full Text] [Related]
19. Unveiling the interactions among BMPR-2, ALK-1 and 5-HTT genes in the pathophysiology of HAPE. Ali Z; Waseem M; Kumar R; Pandey P; Mohammad G; Qadar Pasha MA Gene; 2016 Aug; 588(2):163-72. PubMed ID: 27196063 [TBL] [Abstract][Full Text] [Related]
20. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis. Eddahibi S; Adnot S Respir Res; 2002; 3(1):9. PubMed ID: 11806844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]